These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 20820840

  • 1. Effects of TJN-598, a new selective phosphodiesterase type IV inhibitor on anti-Thy1 nephritis in rats.
    Sadakane C, Kase Y, Koseki J, Hasegawa Y, Shindo S, Maruyama H, Takeda S, Takeda H, Hattori T.
    Clin Exp Nephrol; 2011 Feb; 15(1):14-24. PubMed ID: 20820840
    [Abstract] [Full Text] [Related]

  • 2. Effect of TJN-331 on anti-Thy1 nephritis in rats via inhibition of transforming growth factor-β1 production.
    Saegusa Y, Sadakane C, Koseki J, Hasegawa Y, Shindo S, Maruyama H, Kase Y, Takeda S, Takeda H, Hattori T.
    Biol Pharm Bull; 2010 Feb; 33(10):1710-5. PubMed ID: 20930380
    [Abstract] [Full Text] [Related]

  • 3. TJN-331 improves anti-glomerular basement membrane nephritis by inhibiting the production of intraglomerular transforming growth factor-beta1.
    Saegusa Y, Sadakane C, Koseki J, Hasegawa Y, Shindo S, Maruyama H, Takeda S, Takeda H, Hattori T.
    Biol Pharm Bull; 2010 Feb; 33(8):1349-54. PubMed ID: 20686230
    [Abstract] [Full Text] [Related]

  • 4. (E)-N-[(3,4-dimethoxyphenethyl)]-N-methyl-3-(3-pyridyl)-2-propenamide (TJN-331) inhibits mesangial expansion in experimental IgA nephropathy in ddY mice.
    Saegusa Y, Sadakane C, Koseki J, Hasegawa Y, Shindo S, Takeda S, Takeda H, Hattori T.
    Clin Exp Nephrol; 2010 Dec; 14(6):528-35. PubMed ID: 20814808
    [Abstract] [Full Text] [Related]

  • 5. TJN-259 improves mesangial lesions in experimental immunoglobulin A nephropathy in ddY mice.
    Sadakane C, Hattori T, Koseki J, Inagaki Y, Hasegawa Y, Shindo S, Takeda S, Takeda H.
    Biol Pharm Bull; 2009 Oct; 32(10):1728-33. PubMed ID: 19801835
    [Abstract] [Full Text] [Related]

  • 6. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
    Chen YM, Chien CT, Hu-Tsai MI, Wu KD, Tsai CC, Wu MS, Tsai TJ.
    Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
    [Abstract] [Full Text] [Related]

  • 7. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
    Jiang JY, Huang XD, Wang Y, Deng AP, Zhou JH.
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
    [Abstract] [Full Text] [Related]

  • 8. Endothelial progenitor cell-derived extracellular vesicles protect from complement-mediated mesangial injury in experimental anti-Thy1.1 glomerulonephritis.
    Cantaluppi V, Medica D, Mannari C, Stiaccini G, Figliolini F, Dellepiane S, Quercia AD, Migliori M, Panichi V, Giovannini L, Bruno S, Tetta C, Biancone L, Camussi G.
    Nephrol Dial Transplant; 2015 Mar; 30(3):410-22. PubMed ID: 25488895
    [Abstract] [Full Text] [Related]

  • 9. Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis.
    Hartner A, Hilgers KF, Bitzer M, Veelken R, Schöcklmann HO.
    J Mol Med (Berl); 2003 Jan; 81(1):32-42. PubMed ID: 12545247
    [Abstract] [Full Text] [Related]

  • 10. Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy1 glomerulonephritis in rats.
    Chen YM, Hu-Tsai MI, Lin SL, Tsai TJ, Hsieh BS.
    Nephrol Dial Transplant; 2003 Dec; 18(12):2505-14. PubMed ID: 14605272
    [Abstract] [Full Text] [Related]

  • 11. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
    Peters H, Wang Y, Loof T, Martini S, Kron S, Krämer S, Neumayer HH.
    Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311
    [Abstract] [Full Text] [Related]

  • 12. Alpha8 integrin in glomerular mesangial cells and in experimental glomerulonephritis.
    Hartner A, Schöcklmann H, Pröls F, Müller U, Sterzel RB.
    Kidney Int; 1999 Oct; 56(4):1468-80. PubMed ID: 10504498
    [Abstract] [Full Text] [Related]

  • 13. Pentoxifylline Attenuates Proteinuria in Anti-Thy1 Glomerulonephritis via Downregulation of Nuclear Factor-κB and Smad2/3 Signaling.
    Chen YM, Chiang WC, Yang Y, Lai CF, Wu KD, Lin SL.
    Mol Med; 2015 Apr 13; 21(1):276-84. PubMed ID: 25879629
    [Abstract] [Full Text] [Related]

  • 14. Usp2-69 overexpression slows down the progression of rat anti-Thy1.1 nephritis.
    Mao X, Luo W, Sun J, Yang N, Zhang LW, Zhao Z, Zhang Z, Wu H.
    Exp Mol Pathol; 2016 Oct 13; 101(2):249-258. PubMed ID: 27640956
    [Abstract] [Full Text] [Related]

  • 15. NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis.
    Peters H, Daig U, Martini S, Rückert M, Schäper F, Liefeldt L, Krämer S, Neumayer HH.
    Kidney Int; 2003 Aug 13; 64(2):509-18. PubMed ID: 12846746
    [Abstract] [Full Text] [Related]

  • 16. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
    Yoshimura A, Inui K, Nemoto T, Uda S, Sugenoya Y, Watanabe S, Yokota N, Taira T, Iwasaki S, Ideura T.
    J Am Soc Nephrol; 1998 Nov 13; 9(11):2027-39. PubMed ID: 9808088
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolic acid: a new approach to the therapy of experimental mesangial proliferative glomerulonephritis.
    Ziswiler R, Steinmann-Niggli K, Kappeler A, Daniel C, Marti HP.
    J Am Soc Nephrol; 1998 Nov 13; 9(11):2055-66. PubMed ID: 9808091
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.